Discovery of high-gain stimulated polariton scattering near 4 THz from lithium niobate.

Lithium niobate is the most popular material for terahertz wave generation via stimulated polariton scattering (SPS), previously known to have a gain peak near 2 THz. Here we report the discovery of another phase-matched gain peak near 4 THz in lithium niobate, which greatly extends the useful gain spectrum of lithium niobate. Despite the relatively high 4 THz absorption in lithium niobate, the 4 THz SPS becomes dominant over the 2 THz one in an intensely pumped short lithium niobate crystal due to less diffraction-induced absorption and mode-area mismatch. We also demonstrate a signal-seeded OTPO that generates 1.4 nJ at 4.2 THz from lithium niobate with 17.5 mJ pump energy.

Efficient 750-nm LED-pumped Nd:YAG laser.

We report an Nd:YAG laser pumped by light emission diodes (LEDs) at 750 nm. With 1% output coupling from a linear cavity containing a 2-cm long Nd:YAG crystal, the laser generated 37.5 µJ pulse energy at 1064 nm with M2 = 1.1 when pumped by 2.73-mJ LED energy in a 1-ms pulse at a 10 Hz rate. The measured optical and slope efficiencies for this linear-cavity laser are 1.36, and 9%, respectively. With 1 and 5% output couplings from a Z-cavity containing the same laser crystal, the lasers generated 346 and 288 µJ pulse energy with an optical efficiency of 3.4 and 2.8% and slope efficiency of 6.6 and 14%, respectively, for the same 1-ms pump pulse repeating at a 10 Hz rate. At the highest output from the Z-cavity, the measured M2 for the beam is 3.6.

Terahertz parametric generation and amplification from potassium titanyl phosphate in comparison with lithium niobate and lithium tantalate.

We report superior terahertz parametric generation from potassium titanyl phosphate (KTP) over congruent-grown lithium niobate (CLN) and lithium tantalate (CLT) in terms of parametric gain and laser damage resistance. Under the same pump and crystal configurations, the signal emerged first from KTP, 5% Mg-doped CLN, CLN, and then finally from CLT. The signal growth rate in KTP was comparable to that in 5%-Mg-doped CLN, but the signal power from KTP reached a much higher value after all the other crystals were damaged by the pump laser. We further demonstrate seeded terahertz parametric amplification in an edge-cut KTP at 5.74 THz. The THz parametric amplifier (TPA) employs a 17-mm long KTP gain crystal, pumped by a passively Q-switched pump laser at 1064 nm and seeded by a continuous-wave diode laser tuned to the signal wavelength at 1086.2 nm. With 5.8-mJ energy in a 520-ps pump pulse and 100-mW seed signal power, we measured 5-W peak-power THz output from the KTP TPA with 22% pump depletion. In comparison, we measured no detectable THz output power from a similar edge-cut CLN TPA under the same pump power, detection scheme, and crystal configuration, when tuning the seed laser wavelength to 1072.2 nm and attempting to generate a radiation at 2.1 THz.

Parametric laser pulse shortening.

We report simultaneous laser pulse shortening and wavelength conversion based on spectral-temporal correlation in high-gain optical parametric generation (OPG). By spectrally filtering the off-peak signal energy, we shortened a 560 ps pump pulse at 1064 nm to an 80 ps signal pulse at 1.5 µm from a 45 mm long PPLN optical parametric generator with 60 µJ pump energy from a passively Q-switched Nd:YAG laser. Using the same technique, we further demonstrated a 3.6 time shortened laser pulse at 1072 nm from noncollinearly phase matched OPG in a 44 mm long lithium niobate crystal with 3 mJ amplified pump energy from the same Nd:YAG laser.

Ultrasensitive Upconversion Nanoparticle Immunoassay for Human Serum Cardiac Troponin I Detection Achieved with Resonant Waveguide Grating.

Selective detection of biomarkers at low concentrations in blood is crucial for the clinical diagnosis of many diseases but remains challenging. In this work, we aimed to develop an ultrasensitive immunoassay that can detect biomarkers in serum with an attomolar limit of detection (LOD). We proposed a sandwich-type heterogeneous immunosensor in a 3 × 3 well array format by integrating a resonant waveguide grating (RWG) substrate with upconversion nanoparticles (UCNPs). UCNPs were used to label a target biomarker captured by capture antibody molecules immobilized on the surface of the RWG substrate, and the RWG substrate was used to enhance the upconversion luminescence (UCL) of UCNPs through excitation resonance. The LOD of the immunosensor was greatly reduced due to the increased UCL of UCNPs and the reduction of nonspecific adsorption of detection antibody-conjugated UCNPs on the RWG substrate surface by coating the RWG substrate surface with a carboxymethyl dextran layer. The immunosensor exhibited an extremely low LOD [0.24 fg/mL (9.1 aM)] and wide detection range (1 fg/mL to 100 pg/mL) in the detection of cardiac troponin I (cTnI). The cTnI concentrations in human serum samples collected at different times during cyclophosphamide, epirubicin, and 5-fluorouracil (CEF) chemotherapy in a breast cancer patient were measured by an immunosensor, and the results showed that the CEF chemotherapy did cause cardiotoxicity in the patient. Having a higher number of wells in such an array-based biosensor, the sensor can be developed as a high-throughput diagnostic tool for clinically important biomarkers.

Covalent linkage of nanodiamond-paclitaxel for drug delivery and cancer therapy.

A nanoparticle-conjugated cancer drug provides a novel strategy for cancer therapy. In this study, we manipulated nanodiamond (ND), a carbon nanomaterial, to covalently link paclitaxel for cancer drug delivery and therapy. Paclitaxel was bound to the surface of 3-5 nm sized ND through a succession of chemical modifications. The ND-paclitaxel conjugation was measured by atomic force microscope and nuclear magnetic resonance spectroscopy, and confirmed with infrared spectroscopy by the detection of deuterated paclitaxel. Treatment with 0.1-50 microg ml(-1) ND-paclitaxel for 48 h significantly reduced the cell viability in the A549 human lung carcinoma cells. ND-paclitaxel induced both mitotic arrest and apoptosis in A549 cells. However, ND alone or denatured ND-paclitaxel (after treatment with strong alkaline solution, 1 M NaOH) did not induce the damage effects on A549 cells. ND-paclitaxel was taken into lung cancer cells in a concentration-dependent manner using flow cytometer analysis. The ND-paclitaxel particles were located in the microtubules and cytoplasm of A549 cells observed by confocal microscopy. Furthermore, ND-paclitaxel markedly blocked the tumor growth and formation of lung cancer cells in xenograft SCID mice. Together, we provide a functional covalent conjugation of ND-paclitaxel, which can be delivered into lung carcinoma cells and preserves the anticancer activities on the induction of mitotic blockage, apoptosis and anti-tumorigenesis.